Lesley Regan

Q: What Schools Are Affiliated With Lesley Regan

Lesley Regan is affiliated with the following schools: Imperial College London

Lesley Regan's AcademicInfluence.com Rankings

Lesley Regan

Philosophy

#8275

World Rank

#11622

Historical Rank

Logic

#5322

World Rank

#6713

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Why Is Lesley Regan Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Dame Lesley Regan is a British gynaecologist, professor of Obstetrics and Gynaecology at Imperial College London and Honorary Consultant at Imperial College Healthcare NHS Trust at St Mary's Hospital. She was the president of the Royal College of Obstetricians and Gynaecologists from 2016 to 2019 – only the second woman to ever hold this role and the first in sixty-four years.

(See a Problem?)

Lesley Regan's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Maternal obesity and pregnancy outcome: a study of 287 213 pregnancies in London (2001) (1688)
Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies) (1997) (1022)
Recurrent miscarriage. (2006) (995)
Thrombophilia in pregnancy: a systematic review (2006) (798)
Epidemiology and the medical causes of miscarriage. (2000) (509)
The risks associated with pregnancy in women aged 35 years or older. (2000) (502)
Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study. (2006) (473)
Hypersecretion of luteinising hormone, infertility, and miscarriage (1990) (469)
Maternal activating KIRs protect against human reproductive failure mediated by fetal HLA-C2. (2010) (440)
An informative protocol for the investigation of recurrent miscarriage: preliminary experience of 500 consecutive cases. (1994) (420)
MRI guidance of focused ultrasound therapy of uterine fibroids: early results. (2004) (419)
Influence of past reproductive performance on risk of spontaneous abortion. (1989) (418)
Risk factors for macrosomia and its clinical consequences: a study of 350,311 pregnancies. (2003) (392)
Natural Selection of Human Embryos: Impaired Decidualization of Endometrium Disables Embryo-Maternal Interactions and Causes Recurrent Pregnancy Loss (2010) (328)
Future pregnancy outcome in unexplained recurrent first trimester miscarriage. (1997) (309)
Obstetric Risks of Pregnancy in Women Less Than 18 Years Old (2000) (303)
Association of maternal killer-cell immunoglobulin-like receptors and parental HLA-C genotypes with recurrent miscarriage. (2008) (301)
Reproductive Outcomes in Women With Congenital Uterine Anomalies Detected by Three‐Dimensional Ultrasound Screening (2001) (283)
Sustained Relief of Leiomyoma Symptoms by Using Focused Ultrasound Surgery (2007) (272)
Natural Selection of Human Embryos: Decidualizing Endometrial Stromal Cells Serve as Sensors of Embryo Quality upon Implantation (2010) (267)
High prospective fetal loss rate in untreated pregnancies of women with recurrent miscarriage and antiphospholipid antibodies. (1995) (245)
Oral contraceptives, hormone replacement therapy, thrombophilias and risk of venous thromboembolism: a systematic review (2005) (227)
Emerging role of Chlamydia and Chlamydia-like organisms in adverse pregnancy outcomes (2008) (221)
Endometrial CD56+ natural killer cells in women with recurrent miscarriage: a histomorphometric study. (1999) (207)
Pregnancy complications in women with recurrent miscarriage associated with antiphospholipid antibodies treated with low dose aspirin and heparin (1999) (206)
A comparative study of the morphology of congenital uterine anomalies in women with and without a history of recurrent first trimester miscarriage. (2003) (202)
Polycystic ovaries and recurrent miscarriage--a reappraisal. (1999) (200)
Is maternal underweight really a risk factor for adverse pregnancy outcome? A population‐based study in London (2001) (199)
Miscarriage matters: the epidemiological, physical, psychological, and economic costs of early pregnancy loss (2021) (199)
Recurrent miscarriage (2006) (197)
Pre-eclampsia, antiretroviral therapy, and immune reconstitution (2002) (194)
A Randomized Trial of Progesterone in Women with Recurrent Miscarriages. (2015) (193)
The health risks and consequences of trafficking in women and adolescents: Findings from a European study (2003) (192)
Factor V Leiden and acquired activated protein C resistance among 1000 women with recurrent miscarriage. (2001) (187)
Recurrent miscarriage: pathophysiology and outcome (2005) (187)
Defective endovascular trophoblast invasion in primary antiphospholipid antibody syndrome-associated early pregnancy failure. (2002) (183)
Immunology: Antiphospholipid antibodies and β2-glycoprotein-I in 500 women with recurrent miscarriage: results of a comprehensive screening approach (1995) (179)
A randomized controlled trial comparing medical and expectant management of first trimester miscarriage. (2004) (158)
Deregulation of the serum- and glucocorticoid-inducible kinase SGK1 in the endometrium causes reproductive failure (2011) (153)
Prospective pregnancy outcome in untreated recurrent miscarriers with thyroid autoantibodies. (1999) (148)
Natural killer cells, miscarriage, and infertility (2004) (146)
Heparin and aspirin attenuate placental apoptosis in vitro: implications for early pregnancy failure. (2005) (145)
Second‐trimester pregnancy loss is associated with activated protein C resistance (1996) (143)
Screening for thrombophilia in high‐risk situations: a meta‐analysis and cost‐effectiveness analysis (2005) (143)
Antiphospholipid antibodies and beta 2-glycoprotein-I in 500 women with recurrent miscarriage: results of a comprehensive screening approach. (1995) (133)
Waddlia chondrophila, a Potential Agent of Human Fetal Death (2007) (128)
A prospective study of the incidence, time of appearance and significance of anti-paternal lymphocytotoxic antibodies in human pregnancy. (1991) (125)
The role and interaction of imprinted genes in human fetal growth (2015) (123)
Does suppressing luteinising hormone secretion reduce the miscarriage rate? Results of a randomised controlled trial (1996) (123)
Heparin prevents programmed cell death in human trophoblast. (2006) (118)
Prevalence of hepatitis C among pregnant women attending an inner London obstetric department: uptake and acceptability of named antenatal testing (2000) (116)
Magnetic resonance‐guided focused ultrasound (MRgFUS) compared with abdominal hysterectomy for treatment of uterine leiomyomas (2009) (106)
Gonadotrophin-Releasing Hormone and Magnetic-Resonance–Guided Ultrasound Surgery for Uterine Leiomyomata (2006) (106)
Placental Pathology, Antiphospholipid Antibodies, and Pregnancy Outcome in Recurrent Miscarriage Patients (2003) (105)
Effects of mode of delivery and infant feeding on the risk of mother‐to‐child transmission of hepatitis C virus (2003) (103)
Term preeclampsia is associated with minimal histopathological placental features regardless of clinical severity (2005) (98)
Magnetic resonance guided focused ultrasound surgery of uterine fibroids--the tissue effects of GnRH agonist pre-treatment. (2006) (93)
Factor V Leiden and recurrent miscarriage-prospective outcome of untreated pregnancies. (2002) (92)
Thromboelastography, whole-blood haemostasis and recurrent miscarriage. (2003) (88)
Impaired expression of endometrial differentiation markers and complement regulatory proteins in patients with recurrent pregnancy loss associated with antiphospholipid syndrome. (2006) (87)
Adverse effects of lupus anticoagulant positive blood sera on placental viability can be prevented by heparin in vitro. (2004) (86)
Regulated expression of signal transducer and activator of transcription, Stat5, and its enhancement of PRL expression in human endometrial stromal cells in vitro. (2002) (86)
Recurrent miscarriage--an aspirin a day? (2000) (83)
Association of bacterial vaginosis with a history of second trimester miscarriage. (1996) (82)
Bone density changes in pregnant women treated with heparin: a prospective, longitudinal study. (1999) (81)
HYdroxychloroquine to Improve Pregnancy Outcome in Women with AnTIphospholipid Antibodies (HYPATIA) Protocol: A Multinational Randomized Controlled Trial of Hydroxychloroquine versus Placebo in Addition to Standard Treatment in Pregnant Women with Antiphospholipid Syndrome or Antibodies (2017) (80)
Placental massive perivillous fibrin deposition associated with antiphospholipid antibody syndrome (2002) (78)
Psychiatric morbidity among patients with recurrent miscarriage (2002) (77)
Recurrent miscarriage and variant alleles of mannose binding lectin, tumour necrosis factor and lymphotoxin α genes (2001) (77)
Placental thrombosis and second trimester miscarriage in association with activated protein C resistance (1996) (75)
Cost-effectiveness of magnetic resonance-guided focused ultrasound surgery for treatment of uterine fibroids (2008) (75)
Reproducibility of three-dimensional ultrasound diagnosis of congenital uterine anomalies. (2003) (74)
Magnetic resonance‐guided percutaneous laser ablation of uterine fibroids (2000) (74)
Aberrations of early trophoblast differentiation predispose to pregnancy failure: lessons from the anti-phospholipid syndrome. (2006) (73)
What determines uptake of pertussis vaccine in pregnancy? A cross sectional survey in an ethnically diverse population of pregnant women in London. (2015) (73)
Anti‐beta 2 glycoprotein 1 and anti‐annexin V antibodies in women with recurrent miscarriage (2001) (71)
Micronized vaginal progesterone to prevent miscarriage: a critical evaluation of randomized evidence (2020) (68)
Pregnancy outcome is not affected by antiphospholipid antibody status in women referred for in vitro fertilization. (2000) (67)
Clinical outcomes following percutaneous magnetic resonance image guided laser ablation of symptomatic uterine fibroids. (2002) (67)
The C677T MTHFR gene mutation is not predictive of risk for recurrent fetal loss (1999) (66)
Genetic thrombophilic mutations among couples with recurrent miscarriage. (2006) (66)
Uterine Artery Doppler in Predicting Pregnancy Outcome in Women With Antiphospholipid Syndrome (2001) (66)
The modern preventative treatment of recurrent miscarriage (1996) (66)
Circulating levels of inhibin A, activin A and follistatin in missed and recurrent miscarriages. (2002) (62)
A prospective study of spontaneous abortion (1988) (61)
The effect of body mass index on the outcome of pregnancy in women with recurrent miscarriage (2012) (60)
Undetected gynaecological disorders in women with renal disease. (1997) (59)
The association of bacterial vaginosis with a history of second-trimester miscarriage (1997) (58)
Unexplained recurrent pregnancy loss. (2014) (58)
Patient suitability for magnetic resonance guided focused ultrasound surgery of uterine fibroids. (2009) (57)
Reduced Levels of Plasma Kisspeptin During the Antenatal Booking Visit Are Associated With Increased Risk of Miscarriage (2014) (55)
PROMISE: first-trimester progesterone therapy in women with a history of unexplained recurrent miscarriages - a randomised, double-blind, placebo-controlled, international multicentre trial and economic evaluation. (2016) (54)
High prospective fetal loss rate in untreated pregnancies of women with recurrent miscarriage and antiphospholipid antibodies (1996) (54)
Placental pathology of recurrent spontaneous abortion: the role of histopathological examination of products of conception in routine clinical practice: a mini review. (2007) (53)
IS ANTIPATERNAL CYTOTOXIC ANTIBODY A VALID MARKER IN THE MANAGEMENT OF RECURRENT ABORTION? (1987) (52)
Comparison of five commercial serological tests for the detection of anti-Chlamydia trachomatis antibodies (2010) (51)
Dynamic imaging of the pelvic floor using an open‐configuration magnetic resonance scanner (2001) (50)
The need to improve fertility awareness (2017) (47)
Human chorionic gonadotrophin for threatened miscarriage. (2010) (47)
High serum luteinizing hormone and testosterone concentrations do not predict pregnancy outcome in women with recurrent miscarriage. (2002) (45)
Glucose production in the human placenta. (2006) (42)
Paternally Expressed, Imprinted Insulin-Like Growth Factor-2 in Chorionic Villi Correlates Significantly with Birth Weight (2013) (41)
Recurrent miscarriage: evidence to accelerate action (2021) (41)
G20210A Prothrombin Gene Mutation: Prevalence in a Recurrent Miscarriage Population (2001) (41)
Safety and five-year re-intervention following magnetic resonance-guided focused ultrasound (MRgFUS) for uterine fibroids. (2014) (40)
Effects of vasoactive agents on intracellular calcium and force in myometrial and subcutaneous resistance arteries isolated from preeclamptic, pregnant, and nonpregnant woman. (2005) (40)
Increased thrombin generation in women with recurrent miscarriage (1998) (40)
Counterfactual thinking and psychological distress following recurrent miscarriage (2007) (39)
Intrauterine haematomas in a recurrent miscarriage population. (2001) (38)
M agnetic-resonance-guided percutaneous laser ablation of uterine fibroids (1999) (38)
Second-trimester pregnancy loss is associated with activated C resistance. (1996) (34)
Reference intervals of gestational sac, yolk sac and embryo volumes using three‐dimensional ultrasound (2009) (34)
Burnout, well-being and defensive medical practice among obstetricians and gynaecologists in the UK: cross-sectional survey study (2019) (34)
Seroprevalence of Coxiella burnetii and Brucella abortus among pregnant women. (2009) (34)
Thrombophilia and pregnancy loss. (2002) (34)
Priorities for research in miscarriage: a priority setting partnership between people affected by miscarriage and professionals following the James Lind Alliance methodology (2017) (32)
Histological chorioamnionitis in relation to clinical presentation at 14-40 weeks of gestation. (2001) (32)
Successful in vitro fertilization pregnancy following magnetic resonance‐guided focused ultrasound surgery for uterine fibroids (2011) (29)
Risks of obstetric complications in multiple pregnancies: an analysis of more than 400 000 pregnancies in the UK (2001) (28)
Robot-assisted uterine artery embolization: a first-in-woman safety evaluation of the Magellan System. (2014) (27)
Effect of tumour necrosis factor-alpha and interleukin 1beta on endothelium-dependent relaxation in rat mesenteric resistance arteries in vitro. (2003) (26)
Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment. (2002) (26)
Glucose production by the human placenta in vivo. (1999) (26)
Antiphospholipid antibodies, infertility and recurrent miscarriage. (1997) (25)
The negative impact of COVID‐19 on contraception and sexual and reproductive health: Could immediate postpartum LARCs be the solution? (2020) (22)
Reduced Testicular Steroidogenesis and Increased Semen Oxidative Stress in Male Partners as Novel Markers of Recurrent Miscarriage. (2019) (22)
A novel method to aid in the visualisation and treatment of uterine fibroids with MRgFUS in patients with abdominal scars. (2010) (22)
Obstetric complications of antiphospholipid antibodies. (1997) (22)
Antiphospholipid antibodies and infertility (2002) (21)
Uncomplicated term vaginal delivery following magnetic resonance-guided focused ultrasound surgery for uterine fibroids (2010) (21)
Interstitial thermo-ablation under MRI guidance for the treatment of fibroids (2000) (20)
Psychological distress in recurrent miscarriage: The role of prospective thinking and role and goal investment (2003) (20)
Antiphospholipid syndrome and pregnancy loss. (1998) (19)
Investigation of the Annexin A5 M2 haplotype in 500 white European couples who have experienced recurrent spontaneous abortion. (2015) (19)
A further look at infection at the time of therapeutic abortion. (1990) (19)
Miscarriage : What Every Woman Needs to Know (1997) (18)
Recurrent early pregnancy failure (1992) (18)
Analysis of CDKN1C in fetal growth restriction and pregnancy loss. (2019) (17)
Obstetric opinions regarding the method of delivery in women that have had surgery for retinal detachment (2011) (16)
Biology and pathology of the placenta in relation to antiphospholipid antibody-associated pregnancy failure (2002) (16)
No evidence for mutations in NLRP7, NLRP2 or KHDC3L in women with unexplained recurrent pregnancy loss or infertility. (2015) (15)
The importance of preconception counseling and early pregnancy monitoring. (2011) (15)
Measurement of uterine fibroid volume: a comparative accuracy and validation of methods study. (2013) (15)
Erratum: Maternal activating KIRs protect against human reproductive failure mediated by fetal HLA-C2 (Journal of Clinical Investigation (2010) 120, 11 (4102-4110) DOI: 10.1172/JCI43998) (2011) (14)
Sporadic miscarriage: evidence to provide effective care (2021) (13)
Racial differences in female urethral morphology and levator hiatal dimensions: An ultrasound study (2012) (13)
Thrombophilia and adverse pregnancy outcome. (2000) (12)
A new biological and clinical resource for research into pregnancy complications: The Baby Bio Bank (2016) (11)
Exome sequencing identifies variants in FKBP4 that are associated with recurrent fetal loss in humans. (2019) (10)
Safety and treatment volumes achieved following new developments of the magnetic resonance-guided focused ultrasound system in the treatment of uterine fibroids: a cohort study (2013) (10)
Ethical Aspects of Human Reproduction (1996) (9)
Complications of pregnancy after infertility treatment: awareness and prevention (1996) (9)
Fractured rib, pleural effusion, and ascites (1998) (9)
Undiagnosed Primary Hyperparathyroidism and Recurrent Miscarriage: The First Prospective Pilot Study (2018) (9)
Action of the endothelin receptor (ETA) antagonist BQ-123 on forearm blood flow in young normotensive subjects. (2002) (9)
Novel circulating placental markers prokineticin-1, soluble fms-like tyrosine kinase-1, soluble endoglin and placental growth factor and association with late miscarriage. (2016) (8)
Obstetrics and Gynaecology (2011) (8)
The British 1967 Abortion Act—still fit for purpose? (2017) (8)
O-126. Pregnancy complications in women with recurrent miscarriage and antiphospholipid antibodies treated with aspirin and heparin (1997) (8)
Recurrent miscarriage. (1991) (7)
Early medical abortion: best practice now lawful in Scotland and Wales but not available to women in England (2018) (7)
Antiphospholipid syndrome in pregnancy (1998) (7)
Vaginal birth after cesarean: the European experience. (2001) (7)
Antiphospholipid antibodies in women undergoing in-vitro fertilization. (1997) (6)
Re: Effect of progestogen for women with threatened miscarriage: a systematic review and meta‐analysis (2020) (6)
Maternal Mortality in the United States Compared With Ethiopia, Nepal, Brazil, and the United Kingdom: Contrasts in Reproductive Health Policies. (2020) (6)
Your Pregnancy Week by Week (2005) (6)
Prenatal ultrasound detection of micrognathia and its association with Robin sequence. (2017) (6)
Analysis of CDKN1C in fetal growth restriction and pregnancy loss (2020) (6)
The use of whole rat embryo culture as a technique for investigating potential serum toxicity in recurrent miscarriage patients. (2000) (6)
Impaired recovery of intracellular calcium and force after activation in isolated myometrial and subcutaneous resistance arteries from women with preeclampsia (2010) (6)
HRT and breast cancer risk (2019) (5)
P-168. The endometrial CD56+ natural killer cell population in women with recurrent miscarriage (1999) (5)
Sporadic and recurrent miscarriage (2011) (5)
Grossly elevated placental derived alkaline phosphatase in pregnancy as a marker for uteroplacental vascular disease. (1999) (5)
A comparative study of the morphology of congenital uterine anomalies in women with and without a history of recurrent ® rst trimester miscarriage (4)
The Baby Bio Bank-A Legacy for Researchers Worldwide into Common Complications of Pregnancy (2014) (4)
O82 Does the volume of retained products of conception and hormonal parameters influence the success of conservative methods of management of first trimester miscarriage? (2009) (4)
Early pregnancy failure after assisted reproductive technology (2012) (3)
Reproductive genetics No evidence for mutations in NLRP 7 , NLRP 2 or KHDC 3 L in women with unexplained recurrent pregnancy loss or infertility (2014) (3)
Ethical Dilemmas in Assisted Reproduction (1998) (3)
Prospective randomised trial of aspirin versus aspirin plus heparin in pregnant women with the antiphospholipid syndrome. (1996) (3)
Recurrent Miscarriage including Cervical Incompetence (2012) (3)
Hypertensive disorders of pregnancy and long‐term cardiovascular health: FIGO Best Practice Advice (2023) (3)
Recurrent miscarriage (1990) (3)
Pre pregnancy thrombophilic abnormalities are associated with subsequent miscarriage (2000) (3)
Interstitial laser coagulation for uterine myomas. (2003) (3)
Screening for heritable thrombophilic risk factors in a recurrent miscarriage population (1999) (2)
P-171. Doppler ultrasound of the uterine artery in the early prediction of pregnancy complications in women with antiphospholipid syndrome (1999) (2)
Pregnancy as an opportunity to prevent type 2 diabetes mellitus: FIGO Best Practice Advice (2023) (2)
The need for a new Tobacco Control Plan: an issue of justice (2017) (2)
Using FIGO Nutrition Checklist counselling in pregnancy: A review to support healthcare professionals (2023) (2)
Comprar Oxford Desk Reference: Obstetrics and Gynaecology | David Farquharson | 9780199552214 | Oxford University Press (2011) (2)
Is the urethra more mobile in women with stress urinary incontinence (2016) (2)
The Endometrium in Recurrent Miscarriage (2002) (2)
O-132. Computerized thromboelastographic parameters amongst women with recurrent miscarriage—evidence for a pro-thrombotic state (1999) (2)
Definitions of adverse events, seriousness and causality (2016) (2)
Spontaneous and Recurrent Abortion: Epidemiological and Immunological Considerations (1988) (2)
Proposed trial: HYPATIA - a prospective randomised controlled trial of hydroxychoroquine vs. placebo during pregnancy in women with antiphospholipid antibodies (2016) (2)
The Aetiology and Management of Recurrent Miscarriage (1992) (2)
Placental infarction and pregnancy outcome; do placental infarcts really occur in genuinely uncomplicated normal pregnancies? (2001) (2)
Screening for thrombophilia: an economic assessment (2003) (2)
The impact of bulky fibroids on LUTS: does either the size or the position make a difference? (2014) (1)
Recurrent miscarriage – the role of prothrombotic disorders (2005) (1)
Sample participant information sheet (2016) (1)
Sample consent form (2016) (1)
3D ultrasound study of uterine anomalies in women with history of recurrent miscarriage (2001) (1)
Management of obesity across women's life course: FIGO Best Practice Advice (2023) (1)
How Can We Achieve Sustainable Development Goal-5: Gender Equality for All by 2030? (2021) (1)
Introduction of specialised placental pathology request forms is associated with appropriate requests and significantly improved clinical information provision (2002) (1)
Granulomatous Orchitis (1983) (1)
Reduced trophoblastic invasion of decidual vessels in recurrent miscarriage patients with antiphospholipid antibodies (2000) (1)
The association between bacterial vaginosis and infertility (1997) (1)
Open letter to Simon Stevens to ensure that tobacco dependence treatment is provided for every smoker cared for by the NHS, as part of the long term plan (2018) (1)
Ultrasound technique for the assessment of urethral descent assessment technique (UDAT) in healthy volunteers (2020) (1)
P-065. Pregnancy outcome in women undergoing in-vitro fertilization is not affected by antiphospholipid antibodies or anti-β2-glycoprotein I antibodies (1999) (0)
O-037. Prospective outcome of untreated pregnancies amongst women with the factor V Leiden genotype and recurrent miscarriage (1999) (0)
Integrating Human Rights and Women’s Health. Competencies for Practice (2017) (0)
Antiphospholipid antibody status and IVF—debate?: the reply (2000) (0)
Pregnancy Morbidity Associated with Thrombophilias: Recurrent Miscarriage (2015) (0)
OC14.02: Anatomic factors in recurrent miscarriage—US and HSG in evaluation of the uterine cavity in 352 women (2011) (0)
What Is Known about HCQ ’ s Use in Patients with Systemic Lupus Erythematosus and APS (2017) (0)
O-026 Spindle morphology in human in vitro matured oocytes after temporary nuclear arrest by phosphodiesterase 3-inhibitor Session – Early pregnancy O-027 Peripheral blood natural killer cells and recurrent miscarriage—a prospective study (2006) (0)
Abortion: View from Westminster (2018) (0)
Richard William Beard (2012) (0)
THE MODERN PREVENTIVE TREATMENT OF RECURRENT MISCARRIAGE. AUTHOR'S REPLY (1996) (0)
The association between early gestational age and placental infarction in pregnancies complicated by severe pre-eclampsia (2004) (0)
Histomorphometric evidence for haemodynamically controlled compensatory umbilical artery enlargement in pregnancies with a single umbilical artery (2001) (0)
Labour care of women with HIV infection (1999) (0)
Abstract No. 80: Effect of uterine fibroid embolization (UFE) on ovarian reserve: early results of a randomized control trial comparing two embolic agents (2012) (0)
Early medical abortion by telemedicine in the United Kingdom: A cost-effectiveness analysis (2021) (0)
Effect of antiphospholipid antibody types on pregnancy outcome (2000) (0)
Labour care of women with HIV infection. Article did not highlight current guidelines. (1999) (0)
method of delivery in women that have had surgery for retinal detachment (2011) (0)
Early Pregnancy: Acquired thrombophilia and recurrent early pregnancy loss (2010) (0)
Racial differences in female urethral sphincter morphology. (2010) (0)
O-252 Next generation sequencing analysis of the seminal microbiome in male partners of women with idiopathic recurrent pregnancy loss: results of a prospective cohort study (2022) (0)
Expression of endometrial complement regulatory proteins in antiphospholipid syndrome. (2006) (0)
Investigation of the Annexin A 5 M 2 haplotype in 500 white European recurrent miscarriage couples (2016) (0)
Reactive oxygen species as a novel metabolic pathway for sperm DNA damage and Recurrent Pregnancy Loss (2017) (0)
Should we offer caesarean section to women who develop stress incontinence after first vaginal delivery (2016) (0)
Pregnancy Morbidity Associated with Hereditary and Acquired Thrombophilias: Recurrent Miscarriage (2012) (0)
??2 Glycoprotein-1 levels and ??2 glycoprotein-1 binding antibodies in patients with recurrent miscarriage (1995) (0)
Abortion Training and Integration in the United Kingdom (2021) (0)
Associations between seminal microbiota composition and ROS in men with fertility disorders (2022) (0)
Testing of peripheral blood NK cells (2004) (0)
Cutaneous anthrax. (2001) (0)
We must seize this once in a lifetime chance. (2016) (0)
Recurrent pregnancy loss ( RPL ) : 2 or more miscarriages < 24 weeks Recurrent early miscarriage (2014) (0)
Undiagnosed primary hyperparathyroidism and recurrent miscarriage: A clinically significant risk? A pilot study (2017) (0)
Body dysmorphic disorder: a clinician's introduction. (2001) (0)
P-170. Polycystic ovaries and recurrent miscarriage a reappraisal (0)
Authors' Reply (1996) (0)
Should progesterone supplements be used?: – Against (2007) (0)
The Baby Bio Bank of London (2009) (0)
Prevalence of anti-beta 2 glycoprotein 1 IgG antibodies in women with recurrent miscarriage (1999) (0)
Table of Contents (2020) (0)
Cloning (2000) (0)
Intrauterine haematomas during pregnancy in patients with recurrent miscarriage; Effects on pregnancy complications (2000) (0)
Can we improve sepsis care, out there? (2016) (0)
Antiphospholipid antibody syndrome-associated maternal floor infarction (2000) (0)
O-130. Prevalence of factor V Leiden genotype amongst 785 consecutive women with recurrent miscarriage (1999) (0)
Celebrating 90 years of advances in women's health (2019) (0)
Use of NCAM immunohistochemistry to identify normal and abnormal endovascular trophoblast invasion in first trimester products of conception (2001) (0)
Sample general practitioner letter (2016) (0)
F013: Myometrial & subcutaneous resistance vessel responses in pre-eclampsia, normal pregnancy and the non-pregnant state to angiotensin II & phenylephrine (2000) (0)
Abortion law in the British Isles: progress needs to become the rule not the exception (2019) (0)
Thrombophilia: An exaggerated prothrombotic response to pregnancy underlies many cases of recurrent pregnancy loss (2000) (0)
I307 INTEGRATING HUMAN RIGHTS AND HEALTH – INTRODUCING THE FIGO PROJECT TO TRANSFORM WOMEN'S HEALTHCARE (2012) (0)
Myocardial infarction during pregnancy (1994) (0)
A core outcome set for trials in miscarriage management and prevention: An international consensus development study. (2023) (0)
Prevalence of antiphospholipid antibodies in women with recurrent pregnancy loss. (1992) (0)
Debate: Should Progesterone Supplements Be Used? No (2014) (0)
OR18-5 Elevated Semen Oxidative Stress in Male Partners as Novel Marker of Recurrent Pregnancy Loss (2019) (0)
Termination of Pregnancy (Abortion) (2018) (0)
Termination of Pregnancy (Abortion) (2018) (0)
Magnetic Resonance-guided Focused Ultrasound for Uterine Fibroids (2013) (0)
Hormone Replacement Therapy: A Critical Review of Current Practice and the Way Ahead (1995) (0)
Placental pathology and pregnancy outcome by antiphospholipid antibody status in recurrent miscarriage patients (2002) (0)
Predisposing factors for birthweight greater than 4kg and its obstetric consequences (2001) (0)
Abortion care as a key women's health service (2017) (0)
PIH17 COST-EFFECTIVENESS OF MAGNETIC RESONANCE-GUIDED FOCUSED ULTRASOUND SURGERY FOR TREATMENT OF UTERINE FIBROIDS (2008) (0)
OC11.08: Magnetic resonance guided focused ultrasound compared to abdominal hysterectomy for treatment of uterine leiomyomas (2009) (0)
Plasma cell deciduitis and pemphigoid gestationalis (2001) (0)
Routine testing for HCV in pregnant women is popular and identifies many women with no obvious risk factors (2000) (0)
A functional polymorphism in the extrapituitary prolactin promoter has opposing effects on prolactin gene expression in T-lymphocytes and endometrial stromal cells but is not associated with unexplained recurrent miscarriages (2003) (0)
Managing miscarriage. (1992) (0)
The ultrasound size of the perineal body is associated with vaginal prolapse (2019) (0)

This paper list is powered by the following services:

Other Resources About Lesley Regan

en.wikipedia.org

What Schools Are Affiliated With Lesley Regan?

Lesley Regan is affiliated with the following schools:

Imperial College London